Results 201 to 210 of about 48,247 (244)

Beyond the Cure: Navigating Hepatocellular Risk and Surveillance after Hepatitis C Eradication in the Direct-acting Antiviral Era. [PDF]

J Clin Transl Hepatol
Xie C, Singal AK.
europepmc   +1 more source

Immunomodulatory Effect of Tilapia (Oreochromis niloticus) Scale Gelatin Peptides in RAW264.7 Macrophages and Caenorhabditis elegans

Food Safety and Health, EarlyView.
ABSTRACT Currently, small‐molecular‐weight collagen peptides are a research hotspot in functional factor development due to their high bioavailability and diverse bioactivities. In this study, gelatin was extracted from tilapia (Oreochromis niloticus) scales by hot water extraction, followed by pepsin hydrolysis and ultrafiltration to obtain the < 3 ...
Ya‐ru Liu, Xu Guo, Shu‐tao Sun, Rui‐rui Zhang, Chao Liu, Ning‐yang Li   +5 more
wiley   +1 more source

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection. [PDF]

J Infect Dis
Truscello E, Wang S, Young J, Sebastiani G, Walmsley SL, Hull M, Cooper C, Klein MB.   +7 more
europepmc   +1 more source

Emerging Therapies for Hepatitis C

Gut and Liver, 2014
doaj   +1 more source

Genetically distinct within-host subpopulations of hepatitis C virus persist after Direct-Acting Antiviral treatment failure. [PDF]

PLoS Pathog
Zhao L, Hall M, Giridhar P, Ghafari M, Kemp S, Chai H, Klenerman P, Barnes E, Ansari MA, Lythgoe K.   +9 more
europepmc   +1 more source

Prevalence and Correlates of Hepatitis C Viremia Among People With Human Immunodeficiency Virus in the Direct-Acting Antiviral Era. [PDF]

Open Forum Infect Dis
Ma J, Nance RM, Cachay E, Ruderman SA, Kitahata M, Falade-Nwulia O, Chander G, Drumright LN, Hurt CB, Yendewa GA, Pettit A, Moore RD, Fredericksen RJ, Lloyd A, Bamford L, Napravnik S, Fleming J, Christopoulos K, Burkholder G, Keruly J, Delaney JAC, Crane H, Kim HN.   +22 more
europepmc   +1 more source

Reply to correspondence on "Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C". [PDF]

Clin Mol Hepatol
Liu CH, Chang YP.
europepmc   +1 more source

The Impact of New Direct-Acting Antiviral Therapy on the Prevalence and Undiagnosed Proportion of Chronic Hepatitis C Infection in Alberta: A Model-Based Analysis. [PDF]

Can Liver J
Forouzannia F, Lewis D, Eze N, Clement F, Wong WWL.   +4 more
europepmc   +1 more source

Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study. [PDF]

Clin Mol Hepatol
Lee SW, Yang SS, Tsai PC, Huang CF, Chen CY, Hung CH, Chen CH, Tai CM, Cheng PN, Kuo HT, Tseng KC, Mo LR, Lo CC, Huang YH, Lin HC, Lee PL, Bair MJ, Chang TS, Lin CY, Wang SJ, Hsieh TY, Yang TH, Peng CY, Yang CC, Chong LW, Huang CW, Lin CW, Chu CH, Tsai MC, Kao JH, Liu CJ, Chuang WL, Lee TY, Yu ML, TACR investigators.   +34 more
europepmc   +1 more source

Change in Estimated Glomerular Filtration Rate After Direct-Acting Antiviral Treatment in Chronic Hepatitis C Patients. [PDF]

Diseases
Dashjamts G, Ganzorig AE, Tsedendorj Y, Daramjav D, Khayankhyarvaa E, Ulziitsogt B, Nergui O, Dondov G, Badamjav T, Lonjid T, Huang CF, Liang PC, Batsaikhan B, Dai CY.   +13 more
europepmc   +1 more source